Literature DB >> 22200085

FOXL2 mutation and large-scale genomic imbalances in adult granulosa cell tumors of the ovary.

Katherine B Geiersbach1, Elke A Jarboe, Mona S Jahromi, Christine L Baker, Christian N Paxton, Sheryl R Tripp, Joshua D Schiffman.   

Abstract

Adult granulosa cell tumors (AGCTs) are a rare class of ovarian tumors with recurrent cytogenetic abnormalities including trisomy 12, trisomy 14, monosomy 16/deletion 16q, and monosomy 22. Over 90% contain a missense point mutation (C134W) in the FOXL2 gene at 3q22.3. The relationship between FOXL2 mutation and cytogenetic abnormalities is unclear, although both are presumably early events in tumorigenesis. In addition, FOXL2 C134W mutant allele imbalance has been noted in a minority of AGCTs, but the mechanism for allelic imbalance has not yet been described. We used a microarray platform designed for formalin-fixed, paraffin-embedded (FFPE) tissue specimens, the Affymetrix OncoScan FFPE Express 330K Molecular Inversion Probe (MIP) array, to explore the correlation between genomic imbalances detected by microarray and FOXL2 mutation status detected by pyrosequencing in a series of 21 archived AGCTs. Tumors were characterized by histopathologic features, stage, and alpha-inhibin expression by immunohistochemistry. All tumors were positive for inhibin, and 18/21 tumors contained a FOXL2 mutation. The most common genomic imbalances were a gain of 14q, a loss of 16q, and a loss of 22q. Three tumors showed evidence of FOXL2 mutant allele imbalance by pyrosequencing; microarray revealed a 32.5 Mb deletion encompassing FOXL2 in 1 case and a 70.9 Mb stretch of homozygosity encompassing FOXL2 in the other case. The third case, with a FOXL2 mutant allele imbalance, showed a diminished mutant allele population (32%) despite high estimated tumor content (>90%), suggesting tumor heterogeneity for the mutation. This study provides the first correlation of FOXL2 mutation status and genomic imbalances in AGCTs, and it further elucidates the mechanisms for mutant allele imbalance in cancer.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22200085     DOI: 10.1016/j.cancergen.2011.10.002

Source DB:  PubMed          Journal:  Cancer Genet


  11 in total

1.  Increased FOXL2 expression alters uterine structures and functions†.

Authors:  Rong Li; San-Pin Wu; Lecong Zhou; Barbara Nicol; John P Lydon; Humphrey H-C Yao; Francesco J DeMayo
Journal:  Biol Reprod       Date:  2020-10-29       Impact factor: 4.285

2.  FOXL2 molecular status in adult granulosa cell tumors of the ovary: A study of primary and metastatic cases.

Authors:  Gian Franco Zannoni; Giuseppina Improta; Marco Petrillo; Angela Pettinato; Giovanni Scambia; Filippo Fraggetta
Journal:  Oncol Lett       Date:  2016-06-14       Impact factor: 2.967

3.  Combined comparative genomic hybridization and transcriptomic analyses of ovarian granulosa cell tumors point to novel candidate driver genes.

Authors:  Sandrine Caburet; Mikko Anttonen; Anne-Laure Todeschini; Leila Unkila-Kallio; Denis Mestivier; Ralf Butzow; Reiner A Veitia
Journal:  BMC Cancer       Date:  2015-04-10       Impact factor: 4.430

4.  Molecular pathogenesis in granulosa cell tumor is not only due to somatic FOXL2 mutation.

Authors:  Wen-Chung Wang; Yen-Chein Lai
Journal:  J Ovarian Res       Date:  2014-09-06       Impact factor: 4.234

5.  Prediction of early-stage hepatocellular carcinoma using OncoScan chromosomal copy number aberration data.

Authors:  Ming-Chin Yu; Chao-Wei Lee; Yun-Shien Lee; Jang-Hau Lian; Chia-Lung Tsai; Yi-Ping Liu; Chun-Hsing Wu; Chi-Neu Tsai
Journal:  World J Gastroenterol       Date:  2017-11-28       Impact factor: 5.742

Review 6.  Implementation and utilization of the molecular tumor board to guide precision medicine.

Authors:  Shuko Harada; Rebecca Arend; Qian Dai; Jessica A Levesque; Thomas S Winokur; Rongjun Guo; Martin J Heslin; Lisle Nabell; L Burt Nabors; Nita A Limdi; Kevin A Roth; Edward E Partridge; Gene P Siegal; Eddy S Yang
Journal:  Oncotarget       Date:  2017-06-14

7.  Clinical and genetic analysis of recurrent adult-type granulosa cell tumor of the ovary: Persistent preservation of heterozygous c.402C>G FOXL2 mutation.

Authors:  Satoshi Yanagida; Michael S Anglesio; Tayyebeh M Nazeran; Amy Lum; Momoko Inoue; Yasushi Iida; Hirokuni Takano; Takashi Nikaido; Aikou Okamoto; David G Huntsman
Journal:  PLoS One       Date:  2017-06-08       Impact factor: 3.240

8.  KMT2D/MLL2 inactivation is associated with recurrence in adult-type granulosa cell tumors of the ovary.

Authors:  R Tyler Hillman; Joseph Celestino; Christopher Terranova; Hannah C Beird; Curtis Gumbs; Latasha Little; Tri Nguyen; Rebecca Thornton; Samantha Tippen; Jianhua Zhang; Karen H Lu; David M Gershenson; Kunal Rai; Russell R Broaddus; P Andrew Futreal
Journal:  Nat Commun       Date:  2018-06-27       Impact factor: 14.919

9.  Adult type granulosa cell tumor: a very rare case of sex-cord tumor of the testis with review of the literature.

Authors:  Dimosthenis Miliaras; Eleftherios Anagnostou; Ioannis Moysides
Journal:  Case Rep Pathol       Date:  2013-05-16

10.  MicroRNAs and Recent Insights into Pediatric Ovarian Cancers.

Authors:  Jessica C Francis; Nonna Kolomeyevskaya; Claire M Mach; Jennifer E Dietrich; Matthew L Anderson
Journal:  Front Oncol       Date:  2013-04-30       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.